Nutex Health Inc (NUTX) - Net Assets
Based on the latest financial reports, Nutex Health Inc (NUTX) has net assets worth $507.31 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($964.63 Million) and total liabilities ($457.32 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Nutex Health Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $507.31 Million |
| % of Total Assets | 52.59% |
| Annual Growth Rate | 43.13% |
| 5-Year Change | 121.02% |
| 10-Year Change | N/A |
| Growth Volatility | 159.02 |
Nutex Health Inc - Net Assets Trend (2008–2025)
This chart illustrates how Nutex Health Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see NUTX market cap.
Annual Net Assets for Nutex Health Inc (2008–2025)
The table below shows the annual net assets of Nutex Health Inc from 2008 to 2025. Also explore how fast is Nutex Health Inc growing its equity to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $423.44 Million | +109.73% |
| 2024-12-31 | $201.89 Million | +155.22% |
| 2023-12-31 | $79.11 Million | -34.26% |
| 2022-12-31 | $120.33 Million | -37.19% |
| 2021-12-31 | $191.58 Million | +30.00% |
| 2020-12-31 | $147.37 Million | +189.89% |
| 2019-12-31 | $50.84 Million | +3495.03% |
| 2018-12-31 | $-1.50 Million | -163.21% |
| 2017-12-31 | $2.37 Million | +140.36% |
| 2016-12-31 | $-5.87 Million | -475.93% |
| 2015-12-31 | $1.56 Million | +34865.44% |
| 2014-12-31 | $-4.49K | -100.81% |
| 2013-12-31 | $556.19K | +81.94% |
| 2012-12-31 | $305.70K | -80.92% |
| 2011-12-31 | $1.60 Million | -19.17% |
| 2010-12-31 | $1.98 Million | +18.89% |
| 2009-12-31 | $1.67 Million | +74.83% |
| 2008-12-31 | $953.88K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nutex Health Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 28498251700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.00K | 0.00% |
| Other Components | $615.63 Million | 186.87% |
| Total Equity | $329.45 Million | 100.00% |
Nutex Health Inc Competitors by Market Cap
The table below lists competitors of Nutex Health Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sansure Biotech Inc
SHG:688289
|
$1.31 Billion |
|
C*Core Technology Co Ltd
SHG:688262
|
$1.31 Billion |
|
SkiStar AB (publ)
ST:SKIS-B
|
$1.31 Billion |
|
i-80 Gold Corp.
NYSE MKT:IAUX
|
$1.31 Billion |
|
China Yuchai International Limited
F:CYD
|
$1.31 Billion |
|
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
SHG:605016
|
$1.30 Billion |
|
Suzhou Victory Precision Manufacture Co Ltd
SHE:002426
|
$1.30 Billion |
|
Xiamen Meiya Pico Information
SHE:300188
|
$1.30 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nutex Health Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 146,344,749 to 329,447,000, a change of 183,102,251 (125.1%).
- Net income of 70,789,000 contributed positively to equity growth.
- Dividend payments of 74,276,000 reduced retained earnings.
- Share repurchases of 5,000,000 reduced equity.
- Other factors increased equity by 191,589,251.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $70.79 Million | +21.49% |
| Dividends Paid | $74.28 Million | -22.55% |
| Share Repurchases | $5.00 Million | -1.52% |
| Other Changes | $191.59 Million | +58.15% |
| Total Change | $- | 125.12% |
Book Value vs Market Value Analysis
This analysis compares Nutex Health Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.42x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.07x to 4.42x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | $3193.56 | $215.33 | x |
| 2009-12-31 | $1.58 | $215.33 | x |
| 2010-12-31 | $1.66 | $215.33 | x |
| 2011-12-31 | $1.34 | $215.33 | x |
| 2012-12-31 | $957.01 | $215.33 | x |
| 2013-12-31 | $1605.11 | $215.33 | x |
| 2014-12-31 | $-12.30 | $215.33 | x |
| 2015-12-31 | $0.76 | $215.33 | x |
| 2016-12-31 | $-2.84 | $215.33 | x |
| 2017-12-31 | $0.57 | $215.33 | x |
| 2018-12-31 | $-0.21 | $215.33 | x |
| 2019-12-31 | $6.84 | $215.33 | x |
| 2020-12-31 | $19.99 | $215.33 | x |
| 2021-12-31 | $29.01 | $215.33 | x |
| 2022-12-31 | $22.65 | $215.33 | x |
| 2023-12-31 | $13.94 | $215.33 | x |
| 2024-12-31 | $28.69 | $215.33 | x |
| 2025-12-31 | $48.76 | $215.33 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nutex Health Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.49%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.09%
- • Asset Turnover: 0.95x
- • Equity Multiplier: 2.79x
- Recent ROE (21.49%) is above the historical average (-30.23%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 42.29% | 0.00% | 0.00x | 1.52x | $308.00K |
| 2009 | 33.24% | 274.55% | 0.12x | 0.97x | $423.17K |
| 2010 | 7.97% | 12.49% | 0.54x | 1.18x | $-40.38K |
| 2011 | -23.92% | -15.04% | 1.23x | 1.29x | $-543.65K |
| 2012 | -531.21% | -101.88% | 2.14x | 2.44x | $-1.65 Million |
| 2013 | 45.04% | 17.14% | 1.36x | 1.93x | $194.87K |
| 2014 | 0.00% | -64.04% | 3.81x | 0.00x | $-683.89K |
| 2015 | 5.37% | 0.00% | 0.00x | 4.89x | $-72.32K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.85 Million |
| 2017 | 24.57% | 1084.99% | 0.02x | 1.41x | $345.16K |
| 2018 | 0.00% | -3079.95% | 0.20x | 0.00x | $-2.66 Million |
| 2019 | 73.91% | 21.56% | 0.54x | 6.33x | $18.09 Million |
| 2020 | 123.50% | 38.67% | 0.89x | 3.60x | $97.39 Million |
| 2021 | 115.65% | 39.99% | 0.84x | 3.44x | $121.13 Million |
| 2022 | -443.11% | -193.70% | 0.51x | 4.50x | $-434.37 Million |
| 2023 | -74.51% | -18.49% | 0.62x | 6.48x | $-51.93 Million |
| 2024 | 35.65% | 10.87% | 0.73x | 4.48x | $37.54 Million |
| 2025 | 21.49% | 8.09% | 0.95x | 2.79x | $37.84 Million |
Industry Comparison
This section compares Nutex Health Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $468,452,981
- Average return on equity (ROE) among peers: 4.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nutex Health Inc (NUTX) | $507.31 Million | 42.29% | 0.90x | $1.31 Billion |
| Acadia Healthcare Company Inc (ACHC) | $1.69 Billion | 7.07% | 1.54x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $34.55 Million | 0.57% | 2.43x | $1.69 Billion |
| agilon health Inc (AGL) | $-284.73 Million | 0.00% | 0.00x | $1.55 Billion |
| Airsculpt Technologies Inc (AIRS) | $83.99 Million | -5.33% | 1.43x | $153.56 Million |
| Amedisys Inc (AMED) | $736.34 Million | 18.45% | 0.59x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $819.68 Million | 8.62% | 1.87x | $624.22 Million |
| American Shared Hospital Service (AMS) | $11.70 Million | 13.68% | 4.25x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $70.71 Million | -7.84% | 4.30x | $325.24 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.52 Billion | 13.82% | 2.26x | $1.53 Billion |
| Astrana Health Inc (ASTH) | $-83.19K | 0.00% | 0.00x | $1.89 Billion |
About Nutex Health Inc
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient … Read more